Glycoscience -- a new frontier in rational drug design

Area of Science:

• Biochemistry and Molecular Biology
• Carbohydrate Chemistry
• Biopharmaceutical Development

Background:

• Glycans are highly diverse biopolymers involved in critical biological processes.
• Their specific interactions with receptors offer therapeutic intervention targets.
• The biotechnology and pharmaceutical industries are increasingly utilizing carbohydrate-based drugs.

Purpose of the Study:

• To present glycoproteins as significant biopharmaceutical targets.
• To provide an overview of the therapeutic potential of glycoproteins and proteoglycans.
• To highlight emerging applications in various disease areas.

Main Methods:

• Review of recent developments in glycobiology, including glycan analysis and synthesis.
• Exploration of clinical trial data for carbohydrate-based compounds.
• Synthesis of information on diverse therapeutic applications.

Main Results:

• Overcoming challenges in glycan analysis and synthesis has accelerated drug development.
• Numerous carbohydrate-based compounds are in clinical trials.
• Glycoproteins show promise in treating inflammation, cancer, infections, and neurological and lysosomal diseases.

Conclusions:

• Glycoproteins represent a vital and versatile class of biopharmaceutical targets.
• Advancements in glycobiology are driving the development of novel carbohydrate-based therapeutics.
• The potential applications span a wide range of unmet medical needs, from cancer to rare diseases.